Albendazole in combination with artesunate to prevent the recurrence of cystic echinococcosis in mice
ZHANG Hong-wei,PENG Xin-yu,ZHANG Shi-jie,A Du-wayi,YANG Hong-qiang,LV Hai-long,SUN Hong,LV You,MA Zhi-gang,LIU Zhen-zhong
DOI: https://doi.org/10.13350/j.cjpb.2010.05.015
2010-01-01
Abstract:Objective To explore the role of artesunate (Art) combined with albendazole liposome (L-Alb) in preventing infection with cystic echinococcosis (C.E) in mice in order to develop a an adjunct to surgery. Methods Test mice were divided into an Art group (100 mg/kg·d,20 mice),L-Alb group (75 mg/kg·d,20 mice),Art-L-Alb group (same dosage,20 mice),and normal sodium group (tales doses,20 mice) that were then subdivided into a continued treatment group and discontinued treatment group with 10 animals each. Also used were mice in a blank control group (10 mice) and immune control group (10 mice). Mice were immunized 3 times with human antigens from the cystic fluid of Echinococcus granulosus to simulate an IgG-positive environment in humans with C.E infection. Before inoculation with protoscoleces,the drugs mentioned above were administered prophylactically by peritoneal injection for 10 days. Then,the mice in continued treatment groups were respectively treated with the aforementioned drugs for three months. When experiment concluded,the rate of C. E infection,cyst wet weight,rate of inhibition,and spleen index were determined. Cysts were removed to observe the pathological changes resulting from HE staining. Blood was collected and serum separated,and ELISA was used to check for changes in IgG4,IgE,and TNF-α. Results After 3 months of treatment,the rate of infection in the Art,L-Alb,and Art-L-Alb groups was 77.8%,80.0%,and 77.8%,respectively,and this rate did not differ significantly from that in the NS group (77.8%) (P0.05). The rate of inhibition in each of the above groups was 68.43%,73.32%,and 80.37% (P0.05). The rate of inhibition for prophylactic use of Art with L-Alb was 24.00%. The spleen index for each of the above groups was (4.7463±0.8321)%,(4.6374±0.7949)%,(4.1218±0.7055)%,and (5.7830±0.5012)%(P0.01). Pathology results indicated that there was cystic damage in the treatment groups. Of the groups,the Art-L-Alb group had intermediate to severe cystic damage while the other treatment groups had slight to intermediate cystic damage. After three months of treatment,the levels of immunoglobulin subtypes IgG4 and IgE and cytokine TNF-α decreased in comparison to those in the NS group. Conclusion Artesunate combined with albendazole was successful at inhibiting the growth of recurrent C.E cysts but lacked ability to prevent recurrence.